Constellation Pharmaceuticals
Latest round
- Series E
Last raised
- Dec 2015
Total raised
- $130M
Investors
- 6
About Constellation Pharmaceuticals
Constellation Pharmaceuticals, Inc.Founded in 2008 and headquartered in Cambridge, US, Constellation Pharmaceuticals, Inc. focuses on innovative cancer therapeutics.7 billion. The transaction is expected to close in the third quarter of 2021.Constellation Pharmaceuticals specializes in developing therapies that target epigenetic mechanisms to treat cancer. Its pipeline includes treatments designed to address various types of malignancies, focusing on significant unmet medical needs in oncology.Constellation Pharmaceuticals aims to advance its pipeline of cancer therapies and plans to expand into new markets following its acquisition by Morphosys AG. The company anticipates launching new treatments in the next few years, focusing on broader geographic reach and partnerships with healthcare providers to facilitate access.
Who invested in Constellation Pharmaceuticals
6 investors across 7 rounds
See all investors in Constellation Pharmaceuticals
Sign up free to see every VC on the cap table, the rounds they joined, and how much each round raised.
Funding rounds
Series E
Dec 1, 2015
Amount
$56M
Investors
Series D
Aug 5, 2014
Amount
$5M
Investors
Series B
May 23, 2011
Amount
$15M
Investors
Series B
May 24, 2010
Amount
$22M
Investors
Series A
Aug 13, 2009
Amount
$17M
Investors
Series A
Oct 16, 2008
Amount
$10M
Investors
Series A
Apr 28, 2008
Amount
$5M
Investors
Questions about Constellation Pharmaceuticals
Who invested in Constellation Pharmaceuticals?
Constellation Pharmaceuticals has 6 investors on record across 7 venture rounds. Sign up free to see every VC on the cap table and the rounds they joined.
How much funding has Constellation Pharmaceuticals raised?
Constellation Pharmaceuticals has raised 7 venture rounds. Sign up free to see how much each round raised and the total.
When did Constellation Pharmaceuticals last raise money?
Constellation Pharmaceuticals's most recent round on record is a Series E, in Dec 2015.
What does Constellation Pharmaceuticals do?
Constellation Pharmaceuticals, Inc.
Where is Constellation Pharmaceuticals headquartered?
Constellation Pharmaceuticals is headquartered in Cambridge, US.
Which VCs invest in companies like Constellation Pharmaceuticals?
Among active investors with capital left to deploy, Andreessen Horowitz, Founders Fund, Accel and Thrive Capital back pharmaceuticals companies at Constellation Pharmaceuticals's stage. Their profiles are linked below.
VCs backing pharmaceuticals startups at Series E
Raising like Constellation Pharmaceuticals? Find the right VCs.
Capital Atlas matches your startup to active investors by stage, sector and region.